Challenges on the provision of palliative care for patients with cancer in low- and middle-income countries: a systematic review of reviews.

Hammoda Abu-Odah, Alex Molassiotis, Justina Liu
Author Information
  1. Hammoda Abu-Odah: School of Nursing, The Hong Kong Polytechnic University, Kowloon, Hong Kong.
  2. Alex Molassiotis: School of Nursing, The Hong Kong Polytechnic University, Kowloon, Hong Kong. alex.molasiotis@polyu.edu.hk.
  3. Justina Liu: School of Nursing, The Hong Kong Polytechnic University, Kowloon, Hong Kong.

Abstract

BACKGROUND: Despite the significant benefits of palliative care (PC) services for cancer patients, multiple challenges hinder the provision of PC services for these patients. Low- and middle-income countries (LMICs) are witnessing a sharp growth in the burden of non-communicable diseases. There is a significant gap between demand and supply of PC in LMICs in current health services. This review aims to synthesise evidence from previous reviews and deliver a more comprehensive mapping of the existing literature about personal, system, policy, and organisational challenges and possible facilitators on the provision of PC services for cancer patients in LMICs.
METHODS: A systematic review of reviews was performed following PRISMA guidelines. PubMed, EMBASE, SCOPUS, PsycINFO, Web of Sciences, CINAHL, and Cochrane Library databases were searched to identify review papers published between 2000 and 2018 that considered challenges and possible facilitators to PC provision. A modified socioecological model was used as a framework for analysing and summarising findings.
RESULTS: Fourteen reviews were included. The reviews varied in terms of aim, settings, and detail of the challenges and possible facilitators. The main challenges of personal and health care systems included knowledge deficits and misunderstandings from patients, families, the general public, and health care providers about PC; and inadequate number of trained workforce. Besides, limited physical infrastructure, insufficient drugs for symptom relief and lack of a comprehensive national plan for implementing PC were the core organisational and policy level challenges that were recognised. Furthermore, the main possible facilitators that were identified included provision of adequate training for health care providers and health education for patients, families and the general public to enhance their knowledge, beliefs, and attitudes to PC. Finally, involvement of policymakers and making drugs available for symptom relief should also be in place to improve the health care systems.
CONCLUSIONS: Understanding challenges to the provision of PC for people with cancer could help in the development of a PC pathway in LMICs. This knowledge could be used as a guide to develop an intervention programme to improve PC. Political influence and support are also required to ensure the sustainability and the provision of high-quality PC.

Keywords

References

  1. Curr Hematol Malig Rep. 2017 Aug;12(4):300-308 [PMID: 28639084]
  2. BMJ Support Palliat Care. 2013 Mar;3(1):18-25 [PMID: 24644323]
  3. Lancet. 2018 Apr 7;391(10128):1391-1454 [PMID: 29032993]
  4. ESMO Open. 2018 Feb 2;3(2):e000285 [PMID: 29464109]
  5. Cancer Med. 2015 Aug;4(8):1196-204 [PMID: 25914253]
  6. Ann Oncol. 2012 Apr;23 Suppl 3:15-28 [PMID: 22628412]
  7. Bull World Health Organ. 2014 Feb 1;92(2):108-16 [PMID: 24623904]
  8. J Pain Symptom Manage. 2007 May;33(5):486-93 [PMID: 17482035]
  9. Agri. 2008 Apr;20(2):20-30 [PMID: 19021007]
  10. J Palliat Med. 2013 Mar;16(3):301-4 [PMID: 23368979]
  11. Ann Oncol. 2013 Dec;24 Suppl 11:xi60-4 [PMID: 24285231]
  12. AIDS Behav. 2017 Aug;21(8):2412-2438 [PMID: 28631228]
  13. Implement Sci. 2009 Jul 14;4:38 [PMID: 19594942]
  14. Palliat Support Care. 2014 Dec;12(6):495-513 [PMID: 24621947]
  15. J Card Fail. 2013 Dec;19(12):842-50 [PMID: 24331204]
  16. Palliat Med. 2016 Mar;30(3):224-39 [PMID: 26405109]
  17. Cancer. 2009 May 1;115(9):1808-12 [PMID: 19235252]
  18. J Educ Health Promot. 2015 Mar 26;4:20 [PMID: 25861665]
  19. PLoS Med. 2009 Jul 21;6(7):e1000097 [PMID: 19621072]
  20. J Palliat Med. 2019 Jun;22(6):663-669 [PMID: 30649985]
  21. J Pain Symptom Manage. 2007 May;33(5):494-9 [PMID: 17482036]
  22. Health Policy Plan. 2008 Sep;23(5):318-27 [PMID: 18701553]
  23. J Palliat Med. 2003 Jun;6(3):391-9 [PMID: 14509484]
  24. Implement Sci. 2015 Apr 21;10:53 [PMID: 25895742]
  25. J Glob Oncol. 2016 Aug 24;3(3):261-270 [PMID: 28717769]
  26. Health Educ Q. 1988 Winter;15(4):351-77 [PMID: 3068205]
  27. Int J Public Health. 2018 Dec;63(9):1047-1057 [PMID: 29974131]
  28. J Pain Symptom Manage. 2009 Nov;38(5):727-37 [PMID: 19692202]
  29. Mt Sinai J Med. 2012 Sep-Oct;79(5):579-85 [PMID: 22976363]
  30. J Pain Symptom Manage. 2009 Mar;37(3):287-96 [PMID: 18823750]
  31. Ochsner J. 2014 Summer;14(2):208-15 [PMID: 24940131]
  32. Palliat Care. 2017 Feb 20;10:1178224216688887 [PMID: 28469439]
  33. J Pain Symptom Manage. 2010 Dec;40(6):899-911 [PMID: 21145468]
  34. BMJ. 2017 Sep 21;358:j4008 [PMID: 28935701]
  35. J Pain Symptom Manage. 2015 May;49(5):861-70 [PMID: 25623924]
  36. Am J Hosp Palliat Care. 2013 Feb;30(1):94-9 [PMID: 22495789]
  37. Pediatr Blood Cancer. 2018 Jun;65(6):e26996 [PMID: 29418063]
  38. Cancer Epidemiol Biomarkers Prev. 2010 Aug;19(8):1893-907 [PMID: 20647400]
  39. Health Aff (Millwood). 2014 Sep;33(9):1612-9 [PMID: 25201666]
  40. J Pain Palliat Care Pharmacother. 2011;25(1):6-18 [PMID: 21426212]
  41. Evid Based Nurs. 2011 Apr;14(2):40-1 [PMID: 21421969]
  42. Br J Haematol. 2011 Sep;154(6):728-35 [PMID: 21707576]
  43. Int Nurs Rev. 2016 Jun;63(2):180-90 [PMID: 26751254]
  44. Cancer J. 2013 Sep-Oct;19(5):410-3 [PMID: 24051614]
  45. Nat Rev Clin Oncol. 2013 Feb;10(2):108-16 [PMID: 23319138]
  46. BMC Palliat Care. 2013 Sep 17;12(1):34 [PMID: 24044631]
  47. Lancet. 2014 May 17;383(9930):1721-30 [PMID: 24559581]
  48. PLoS One. 2015 Mar 26;10(3):e0120827 [PMID: 25812117]
  49. Ann Oncol. 2013 Dec;24 Suppl 11:xi14-23 [PMID: 24285225]
  50. Lancet. 2005 Aug 27-Sep 2;366(9487):774-9 [PMID: 16125596]
  51. Health Educ Behav. 2012 Jun;39(3):364-72 [PMID: 22267868]
  52. Ecancermedicalscience. 2016 Jul 07;10:655 [PMID: 27563350]
  53. J Clin Oncol. 2016 Jan 1;34(1):62-8 [PMID: 26578612]
  54. Palliat Med. 2010 Dec;24(8):812-9 [PMID: 20501511]
  55. J Pain Palliat Care Pharmacother. 2010 Sep;24(3):239-43 [PMID: 20718644]
  56. J Pain Symptom Manage. 2014 Oct;48(4):649-59.e1 [PMID: 24703944]
  57. J Am Geriatr Soc. 2010 Nov;58(11):2114-21 [PMID: 21054292]
  58. Intern Emerg Med. 2016 Aug;11(5):713-8 [PMID: 26895033]
  59. Lancet Oncol. 2017 Mar;18(3):e176-e184 [PMID: 28271872]
  60. Ann Oncol. 2013 Dec;24 Suppl 11:xi7-13 [PMID: 24436961]
  61. J Pain Palliat Care Pharmacother. 2014 Jun;28(2):130-4 [PMID: 24779434]
  62. Hematol Oncol Stem Cell Ther. 2015 Jun;8(2):64-70 [PMID: 25732671]
  63. Scand J Public Health. 2018 Jun;46(4):478-487 [PMID: 29301481]
  64. J Urban Health. 2004 Mar;81(1):106-17 [PMID: 15047789]
  65. Lancet Oncol. 2018 Jul;19(7):e359-e364 [PMID: 30084383]
  66. N Engl J Med. 1982 Mar 18;306(11):639-45 [PMID: 7057823]
  67. Am J Hosp Palliat Care. 2018 Mar;35(3):431-439 [PMID: 28631493]
  68. Lancet Oncol. 2003 Jan;4(1):5 [PMID: 12517528]
  69. CA Cancer J Clin. 2015 Jul-Aug;65(4):316-33 [PMID: 25955682]
  70. Mayo Clin Proc. 2015 Aug;90(8):996-1000 [PMID: 26211600]
  71. Ann Intern Med. 2015 Oct 20;163(8):637-8 [PMID: 26258800]
  72. J Clin Oncol. 2003 Dec 1;21(23 Suppl):253s-265s [PMID: 14645405]
  73. Am J Hosp Palliat Care. 2001 Jul-Aug;18(4):251-5 [PMID: 11467099]
  74. Ann Palliat Med. 2014 Jul;3(3):129-38 [PMID: 25841689]
  75. J Pediatr Hematol Oncol. 2011 Apr;33 Suppl 1:S64-7 [PMID: 21448041]
  76. Support Care Cancer. 2011 Aug;19(8):1239-47 [PMID: 21637974]
  77. J Pain Symptom Manage. 2015 Oct;50(4):516-23.e2 [PMID: 26025273]
  78. Support Care Cancer. 2010 Feb;18(2):255-63 [PMID: 19609571]
  79. CA Cancer J Clin. 2018 Nov;68(6):394-424 [PMID: 30207593]
  80. Ann Oncol. 2010 Mar;21(3):615-626 [PMID: 20176694]
  81. BMJ Qual Saf. 2013 May;22(5):414-23 [PMID: 23293118]
  82. J Pain Symptom Manage. 2008 Jun;35(6):583-93 [PMID: 18395401]
  83. Mater Sociomed. 2017 Jun;29(2):114-118 [PMID: 28883774]
  84. Indian J Palliat Care. 2016 Oct-Dec;22(4):373-377 [PMID: 27803557]
  85. Qual Saf Health Care. 2006 Oct;15(5):307-10 [PMID: 17074863]
  86. J Pain Symptom Manage. 2014 Feb;47(2):283-97 [PMID: 23870413]
  87. Am J Med. 2019 Feb;132(2):129-131 [PMID: 30076826]
  88. Aust Nurs Midwifery J. 2014 May;21(10):38 [PMID: 24941569]
  89. J Pediatr Hematol Oncol. 2011 Apr;33 Suppl 1:S70-2 [PMID: 21448043]
  90. Eur J Cancer. 1999 Oct;35(11):1592-7 [PMID: 10673967]
  91. N Engl J Med. 2004 Jun 17;350(25):2582-90 [PMID: 15201415]

MeSH Term

Developing Countries
Health Care Costs
Humans
Neoplasms
Organizational Culture
Palliative Care
Poverty

Word Cloud

Created with Highcharts 10.0.0PCcarechallengesprovisionpatientshealthreviewsservicescancerLMICsreviewpossiblefacilitatorscountriesincludedknowledgesignificantpalliativemiddle-incomecomprehensivepersonalpolicyorganisationalsystematicusedmainsystemsfamiliesgeneral publicprovidersdrugssymptomreliefalsoimproveChallengesBACKGROUND:DespitebenefitsmultiplehinderLow-witnessingsharpgrowthburdennon-communicablediseasesgapdemandsupplycurrentaimssynthesiseevidencepreviousdelivermappingexistingliteraturesystemMETHODS:performedfollowingPRISMAguidelinesPubMedEMBASESCOPUSPsycINFOWebSciencesCINAHLCochraneLibrarydatabasessearchedidentifypaperspublished20002018consideredmodifiedsocioecologicalmodelframeworkanalysingsummarisingfindingsRESULTS:FourteenvariedtermsaimsettingsdetaildeficitsmisunderstandingsinadequatenumbertrainedworkforceBesideslimitedphysicalinfrastructureinsufficientlacknationalplanimplementingcorelevelrecognisedFurthermoreidentifiedadequatetrainingeducationenhancebeliefsattitudesFinallyinvolvementpolicymakersmakingavailableplaceCONCLUSIONS:UnderstandingpeoplehelpdevelopmentpathwayguidedevelopinterventionprogrammePoliticalinfluencesupportrequiredensuresustainabilityhigh-qualitylow-countries:CancerLow-incomeMiddle-incomePalliative

Similar Articles

Cited By